- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04832386
COMPRESSION GARMENTS in BREAST CANCER-RELATED LYMPHEDEMA
April 2, 2021 updated by: Banu Dilek, Dokuz Eylul University
COMPLIANCE TO COMPRESSION GARMENTS AND RELATED FACTORS AMONG PATIENTS With BREAST CANCER-RELATED LYMPHEDEMA
Breast cancer is the most common cancer in women.
It is an important health problem that has been increasingly encountered in recent years.
With the advances in treatment, the survival time after breast cancer is prolonged, and as a result, many women face certain diseases during this period.
One of these diseases, breast cancer-related lymphedema, is characterized by abnormal accumulation of protein-rich fluid in the interstitial tissue, which can occur at any time after breast cancer surgery or radiotherapy and is a major cause of morbidity.
The aims of the treatment of lymphedema are to reduce edema, prevent the increase of edema, prevent infections, protect skin integrity, range of motion and limb functions.
Complete Decongestive Therapy (CDT) is recommended by the International Society of Lymphology (ISL) as the international contemporary standard treatment for BCRL(breast cancer related lymphedema) treatment.
CDT is a treatment method that includes manual lymph drainage (MLD), multilayer bandaging (Multilayer, short-stretch compression bandaging), exercise, skin care and compression garment.
Compression garments, which are the most important component of the second phase of CDT, reduce the interstitial pressure of the extremity with the pressure they apply, and reduce capillary filtration and lymph production.
Regular use of compression garments is very important during the treatment process.
It is recommended that compression garments be worn during all waking hours.
The success of compression garments is closely related to the patient's compliance with the treatment.
Patients with lymphedema may need to wear compression garments for life.
Wearing compression garments may have some difficulties for patients and this may affect compliance and adherence to treatment.
The aim of this study is to investigate the compliance to compression garments and related factors among patients with breast cancer-related lymphedema.
Study Overview
Status
Completed
Conditions
Detailed Description
This study was planned as a cross-sectional study.
Patients diagnosed with unilateral breast cancer-related lymphedema and recommended compression garments will be included in the study on a voluntary basis, after obtaining their written consent.
Patients who have received a standard treatment and an education about the use of compression garments from a single center will be asked to answer our 28-question questionnaire about the use of compression garments.
The patients will be asked whether compression garments were recommended or not, how long they have used compression garments, the type and model of the recommended compression garment, whether they can buy the recommended compression garment, how often it is changed, how long it is recommended to wear it during the day, whether it is used for the recommended time, how long wore during the day, the reasons for using and not using the garment.
Compliance to compression garments and the factors affecting this will be questioned.
Patients who use their garments for the recommended time and manner and those who do not will be compared in terms of these factors.
Patients who used their garments for the recommended time and manner will be considered as compliant.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Izmir, Turkey, 35340
- Dokuz Eylul University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Diagnosed with breast cancer releated lymphedema
Description
Inclusion Criteria:
- Being over 18 years of age
- Diagnosed with breast cancer related lymphedema
- Having been prescribed compression garments
Exclusion Criteria:
- cognitive and / or psychiatric illness
- refusal to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
28-questionnaire about the use of compression garments
Time Frame: baseline
|
Patients will be asked to answer our 28-questionnaire about the use of compression garments.
Patients who used their garments for the recommended time and manner will be considered as compliant.
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2019
Primary Completion (Actual)
August 29, 2019
Study Completion (Actual)
August 29, 2019
Study Registration Dates
First Submitted
March 22, 2021
First Submitted That Met QC Criteria
April 2, 2021
First Posted (Actual)
April 5, 2021
Study Record Updates
Last Update Posted (Actual)
April 5, 2021
Last Update Submitted That Met QC Criteria
April 2, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DokuzEU.Com.Garments
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer Lymphedema
-
Odense University HospitalZealand University Hospital; Vejle Hospital; Herlev and Gentofte HospitalRecruitingLymphedema | Breast Cancer Lymphedema | Lymphedema, Breast Cancer | Lymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema Arm | Lymphedema; SurgicalDenmark
-
Koya Medical, Inc.RecruitingLymphedema | Lymphedema, Breast Cancer | Lymphedema ArmUnited States
-
Odense University HospitalDanish Cancer SocietyActive, not recruitingPathologic Processes | Neoplasms | Skin Diseases | Lymphatic Diseases | Postoperative Complications | Breast Cancer | Breast Diseases | Lymphedema | Breast Neoplasm | Surgery | Secondary Lymphedema | Breast Cancer Lymphedema | Lymphedema, Breast Cancer | Lymphedema of Upper Limb | Lymphedema Arm | Iatrogenic Lymphedema | A... and other conditionsDenmark
-
Hacettepe UniversityCompletedLymphedema, Breast CancerTurkey
-
Koya Medical, Inc.RecruitingLymphedema | Lymphedema of Upper Arm | Lymphedema, Breast CancerUnited States
-
Instituto Nacional de Cancer, BrazilRecruitingBreast Neoplasms | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema | Lymphedema, SecondaryBrazil
-
Instituto Nacional de Cancer, BrazilCompletedBreast Neoplasms | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema | Lymphedema, SecondaryBrazil
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerSpain, Switzerland, United States, Germany, Argentina, Austria, Belgium, Brazil, Canada, Greece, Italy, Netherlands, Romania, Sweden
-
Massachusetts General HospitalHeinz Family FoundationRecruitingBreast Cancer | Lymphedema | Edema | Lymphedema of Upper Arm | Breast Cancer Lymphedema | Breast Cancer Metastatic | Lymphedema of Upper Limb | Breast Cancer Stage | Lymphedema Arm | Edema Arm | Lymphedema of the HandsUnited States
-
Izmir Bakircay UniversityBezmialem Vakif University; Istanbul Kent UniversityCompletedLymphedema, Breast Cancer | Lymphedema of Upper LimbTurkey